A method for treating or inhibiting artery obstructive disease, such as restenosis after angioplasty and stenting procedures and stenosis after coronary artery bypass surgery, in a subject by administering to the subject a therapeutically effective amount of dasatinib or a derivative thereof. Also provided are drug-eluting medical devices, including stents, having a therapeutically effective amount of dasatinib.
Wu, Jie; Chen, Zhengming; and Bhalla, Kapil N., "Treatment of restenosis and stenosis with dasatinib" (2014). USF Patents. 152.
University of South Florida H. Lee Moffitt Cancer Center and Research Institute, Inc.